Details of the Drug

General Information of Drug (ID: DMDIRCM)

Drug Name

BTL-TML

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04522830) A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19 (BTL-TML-COVID). U.S. National Institutes of Health.